Schonfeld Strategic Advisors LLC Entera Bio Ltd. Transaction History
Schonfeld Strategic Advisors LLC
- $15.2 Billion
- Q3 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 566,956 shares of ENTX stock, worth $1.54 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
566,956
Previous 604,522
6.21%
Holding current value
$1.54 Million
Previous $1.15 Million
5.75%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ENTX
# of Institutions
25Shares Held
9.21MCall Options Held
21.1KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$15.9 Million6.34% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.18MShares$3.19 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0627KShares$1.7 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT281KShares$761,0270.07% of portfolio
-
Northern Trust Corp Chicago, IL149KShares$402,8900.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $78.1M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...